Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plinabulin vs pegfilgrastim for chemotherapy-induced neutropenia in breast cancer (PK/PD Phase II)
CTR20171050Phase 2Completed
- Sponsor
- BeyondSpring Inc.
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plinabulin in breast cancer, chemotherapy-induced neutropenia (CIN), sponsored by BeyondSpring Inc.. Started Dec 2017; status: completed.
02
Drugs
plinabulin
03
Conditions
breast cancerchemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on CTR20171050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171050.